Sun Pharma’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) for the quarter increased by 19.2% from last year to ₹4,302 crore, which is higher than the CNBC-TV18 poll of ₹3,77 crore.
Sun Pharma’s Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) for the quarter increased by 19.2% from last year to ₹4,302 crore, which is higher than the CNBC-TV18 poll of ₹3,77 crore.